Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden

Catherine Isitt, Daniel Sjöholm, Maria-Pia Hergens, Fredrik Granath, Pontus Nauclér
doi: https://doi.org/10.1101/2021.09.02.21263046
Catherine Isitt
1Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
2Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Sjöholm
3Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria-Pia Hergens
2Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Sweden
4Department of Communicable Disease Control and Prevention, Stockholm County Council, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Granath
3Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pontus Nauclér
1Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
2Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pontus.naucler@sll.se
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.09.02.21263046
History 
  • September 7, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Catherine Isitt1,2,*,
  2. Daniel Sjöholm3,*,
  3. Maria-Pia Hergens2,4,
  4. Fredrik Granath3 and
  5. Pontus Nauclér1,2,†
  1. 1Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
  2. 2Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Sweden
  3. 3Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Karolinska University Hospital, Sweden
  4. 4Department of Communicable Disease Control and Prevention, Stockholm County Council, Stockholm, Sweden
  1. ↵†Contact information: Corresponding author Pontus Nauclér pontus.naucler{at}sll.se,
  1. ↵* Catherine Isitt and Daniel Sjöholm contributed equally to this manuscript

Back to top
PreviousNext
Posted September 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden
Catherine Isitt, Daniel Sjöholm, Maria-Pia Hergens, Fredrik Granath, Pontus Nauclér
medRxiv 2021.09.02.21263046; doi: https://doi.org/10.1101/2021.09.02.21263046
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden
Catherine Isitt, Daniel Sjöholm, Maria-Pia Hergens, Fredrik Granath, Pontus Nauclér
medRxiv 2021.09.02.21263046; doi: https://doi.org/10.1101/2021.09.02.21263046

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (423)
  • Anesthesia (97)
  • Cardiovascular Medicine (902)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8806)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1870)
  • Geriatric Medicine (179)
  • Health Economics (389)
  • Health Informatics (1293)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (397)
  • Infectious Diseases (except HIV/AIDS) (10587)
  • Intensive Care and Critical Care Medicine (565)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1767)
  • Nursing (105)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (967)
  • Ophthalmology (285)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (558)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1847)
  • Public and Global Health (3996)
  • Radiology and Imaging (656)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (198)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)